| Previous Close | 14.08 |
| Open | 14.12 |
| Bid | 12.52 x 2900 |
| Ask | 14.10 x 1800 |
| Day's Range | 13.64 - 14.09 |
| 52 Week Range | 13.53 - 20.00 |
| Volume | 2,160 |
| Avg. Volume | 344,215 |
| Market Cap | 463.642M |
| Beta (3Y Monthly) | 2.05 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 0.05 (0.35%) |
| Ex-Dividend Date | 2018-10-11 |
| 1y Target Est | N/A |
Invacare Corporation announces that it will release its financial results for the third quarter ended September 30, 2018, after the market closes on Monday, November 5, 2018.
NEW YORK, Oct. 12, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares payable October 26, 2018 to shareholders of record on October 12, 2018.
Invacare Corporation (IVC) today announced its conference schedule for September 2018. On Wednesday, September 12, at 5:25 p.m. ET, Matthew E. Monaghan, chairman, president and chief executive officer will present at the Morgan Stanley 2018 Global Healthcare Conference at the Grand Hyatt in New York. The live webcast of the presentation will be available at https://cc.talkpoint.com/morg007/091218a_as/?entity=29_68B6B6D and it will be accessible for replay for 90 days following the conference.
NEW YORK, Aug. 13, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of East ...
NEW YORK, NY / ACCESSWIRE / August 8, 2018 / Invacare Corporation (NYSE: IVC ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 8, 2018 at 8:30:00 AM Eastern Time. ...
Invacare Corporation today reported results for the quarter ended June 30, 2018.
Invacare Corporation announces that it will release its financial results for the second quarter ended June 30, 2018, after the market closes on Tuesday, August 7, 2018.
Matthew E. Monaghan, chairman, president and chief executive officer and Kathy Leneghan, senior vice president and chief financial officer of Invacare Corporation , will participate in the 3rd Annual Needham MedTech 1x1 Conference in Boston on Tuesday, August 7, 2018.
Invacare Corporation (IVC) today announced the appointment of Diana S. Ferguson, to its Board of Directors, effective July 19, 2018. Ms. Ferguson currently serves as Chief Financial Officer for Cleveland Avenue, LLC, a privately-held venture capital firm which accelerates and strategically invests in innovative restaurant, food and beverage concepts and emerging brands. In addition, since August 2013, Ms. Ferguson has served as Principal of Scarlett Investments, LLC, a firm that invests in and advises middle market businesses.
Matthew E. Monaghan, chairman, president and chief executive officer of Invacare Corporation , will present at the 18th Annual “New Ideas” Summer Conference in New York, on Tuesday, July 10, 2018.
Invacare Corporation (IVC) today announced the appointment of Petra Danielsohn-Weil, PhD, to its Board of Directors, effective May 17, 2018. From 2014 until her retirement in August 2017, Ms. Danielsohn-Weil was the Regional President for Pfizer Essential Health - Europe, a leader in non-viral anti-infectives, biosimilars and sterile injectable medicines and a unit of Pfizer Inc. (PFE), a research-based, global biopharmaceutical company.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable July 20, 2018 to shareholders of record on July 6, 2018.
Invacare Corporation today reported results for the quarter ended March 31, 2018.
Invacare Corporation announces that it will release its financial results for the first quarter ended March 31, 2018, after the market closes on Monday, May 7, 2018.
Invacare Corporation today announced the appointment of Kathleen P. Leneghan as Senior Vice President and Chief Financial Officer, effective immediately. Ms. Leneghan has been in the role of interim Chief Financial Officer of the company since November 26, 2017.
The Board of Directors of Invacare Corporation announced that it declared a cash dividend of $.0125 per share on its common shares and $.011364 per share on its Class B common shares payable April 18, 2018 to shareholders of record on April 4, 2018.
Invacare Corporation today announced that it will transfer production of Küschall® manual wheelchairs from its facility in Witterswil, Switzerland to its wheelchair manufacturing facility in Fondettes, France by the end of the third quarter 2018.
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Invacare Corporation (NYSE: IVC ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 8, 2018 at 8:30 AM Eastern Time. ...
Invacare Corporation today announced its financial results for the fourth quarter and year ended December 31, 2017.
Invacare Corporation announces that it will release its financial results for the fourth quarter and year ended December 31, 2017, after the market closes on Wednesday, February 7, 2018.
Matthew E. Monaghan, Chairman, President and Chief Executive Officer of Invacare Corporation , will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 11, 2018 at 9:30 a.m.
Invacare Corporation today announced a reduction in force in North America that is expected to generate approximately $8.5 million in annualized pre-tax savings.